loading page

Effectiveness of 6-shogaol in potentiating sevoflurane mediated neuroprotection against ischemia/reperfusion-induced brain injury via regulating apoptotic proteins and PI3K/Akt/mTOR/s6K signalling and HIF-1α/HO-1 expression
  • +2
  • Junqiao Zhang,
  • Yongxiang Li,
  • Yicai Li,
  • Hongwei Liu,
  • Mengmeng Zhang
Junqiao Zhang
Affiliated Hospital of Weifang Medical University
Author Profile
Yongxiang Li
Affiliated Hospital of Weifang Medical University
Author Profile
Yicai Li
Affiliated Hospital of Weifang Medical University
Author Profile
Hongwei Liu
Affiliated Hospital of Weifang Medical University
Author Profile
Mengmeng Zhang
Affiliated Hospital of Weifang Medical University
Author Profile

Abstract

Purpose: The current research has been intended to evaluate the impacts of 6-shogaol in rodent model of ischemic-reperfusion induced- brain injury and also assessed whether 6-shogaol enhanced sevoflurane’s neuroprotective effects. Methods: Ischemic-Reperfusion (I/R) injury was induced by middle cerebral artery occlusion (MCAO) method in Sprague-Dawley rats. A separate group of animals was exposed to sevoflurane (2.5%) post-conditioning for 1 h immediately after reperfusion. 6-shogaol (25 mg or 50 mg/kg body weight) was orally administered to treatment group rats for 14 days and then subjected to I/R. Results: 6-shogaol treatment along with/without sevoflurane post-conditioning reduced the number of apoptotic cell counts, brain edema and cerebral infarct volume. The western blotting analysis revealed a significant stimulation of the PI3K/Akt/mTOR signal pathway. RT-PCR and western blotting studies revealed improved expressions of HIF-1α and HO-1were also noticed at both gene level and protein levels as determined by. I/R induced neurological deficits were also alleviated on sevoflurane post-conditioning with/without 6-shogaol treatment. Conclusion: The study’s findings reveal that pre-treatment with 6-shogoal enhanced the neuroprotective properties of sevoflurane post-conditioning, illustrating the efficacy of the compound against I/R injury. 6-Shogaol thus could be investigated further for cerebral protection following I/R.